Advanceconcept Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Ebitda
- Net Worth 22.95%
(FY 2022)
- Total Assets 24.30%
(FY 2022)
About Advanceconcept Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nawal Gupta, Shalini Maheshwari, Nandini Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U51900UP2014PTC061906
- Company No.
061906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Advanceconcept Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nawal Gupta  | Director | 10-Jan-2014 | Current |
| Shalini Maheshwari | Director | 03-Apr-2014 | Current |
| Nandini Gupta | Director | 10-Sep-2024 | Current |
| Aryawardhan Gupta | Director | 10-Sep-2024 | Current |
Financial Performance of Advanceconcept Pharmaceuticals.
Advanceconcept Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 22.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Advanceconcept Pharmaceuticals?
In 2016, Advanceconcept Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sheel Resorts Private LimitedActive 3 years 3 monthsNawal Gupta and Shalini Maheshwari are mutual person
- Gangasheel Agro Products Private LimitedActive 3 years 2 months
Shalini Maheshwari, Nandini Gupta and 1 more are mutual person
- Aryawardhan Hospitality Services Private LimitedActive 8 years 4 months
Shalini Maheshwari, Nandini Gupta and 1 more are mutual person
- Sheel Infotech Private LimitedActive 4 years 29 days
Shalini Maheshwari, Nandini Gupta and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advanceconcept Pharmaceuticals?
Advanceconcept Pharmaceuticals has a workforce of 4 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanceconcept Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanceconcept Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
